7th Annual Cambridge Healthtech Institute’s Immuno-Oncology Summit
Powering Next Generation Targeted Immunotherapies
Monday, August 5th – Friday August 9th
Westin Boston Waterfront
425 Summer Street
Boston, MA 02210
Jay Berzofsky, Chief of the Vaccine Branch at the NCI/NIH, chairing the plenary session on personalized vaccines
UPDATE:
EpiVax Oncology (EO) would like to thank everyone who attended Synthetic Genomics/Janssen’s presentation at the summit. The data show how EO’s neoantigen prediction platform, Ancer™, powered by machine learning based algorithms, is designed to enable the discovery of highly immunogenic neoantigens for precision cancer immunotherapies.
Learn more about this revolutionary technology by visiting EpiVax’s publications page, and searching “Ancer” under Subject.
Will you be at this year’s Immuno-Oncology Summit? If so, then we encourage you to sit in Synthetic Genomics‘ presentation on Friday, August 9, at 10:35A.M.
Our collaborator Synthetic Genomics will be presenting their data from their joint research with EpiVax Oncology’s Ancer selected neoantigens and RNA replicon-based personalized vaccines. Their presentation is one of many that will be featured as part of the Personalized Cancer Vaccines track.
READ SYNTHETIC GENOMICS’ ABSTRACT HERE!
ABOUT THE IMMUNO-ONCOLOGY SUMMIT:
Join over 675 IO thought leaders at this leading annual meeting. Learn about the latest research in immuno-oncology through a comprehensive 12-track program. Network with decision makers and build lasting collaborations with an international mix of delegates.
To learn more about the summit and/or to register, please visit CHI’s official event page.